Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03561454 · ClinicalTrials.gov registry record

A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients

A clinical trial of Early Stage Breast Cancer, sponsored by MedStar Franklin Square Medical Center.

Active
Registry status
100
Enrollment target
1
Study location

NCT03561454: Active study of Early Stage Breast Cancer, sponsored by MedStar Franklin Square Medical Center.

NCT03561454 is a study of Early Stage Breast Cancer that is active but no longer recruiting, run by MedStar Franklin Square Medical Center. The registered enrollment target is 100 participants, below the 409-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03561454, a study of Early Stage Breast Cancer, is active but no longer recruiting, sponsored by MedStar Franklin Square Medical Center.

ACTIVE NOT RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Single arm, prospective, multi-center, non-randomized study of subjects treated with single fraction, intra-operative radiation therapy at the time of lumpectomy for early stage breast cancer.To assess the rate of ipsilateral breast tumor recurrence in subjects treated with the Xoft Axxent Electronic Brachytherapy System when used for single-fraction, intra-operative radiation therapy treatment of early stage breast cancer when compared to whole breast irradiation (WBI) at 5 years of follow-up. The results of this single arm study will be compared to whole breast irradiation (WBI).

Conditions Studied

Interventions

  • DEVICE IORT

Study Locations (1)

Maryland

  • MedStar Good Samaritan Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-01-11
Est. Completion 2029-08-01

What the registry record for NCT03561454 still lists

NCT03561454 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 409-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (76% lower).

The record links to 1 condition, with Early Stage Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT is the first listed.

NCT03561454 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03561454 about?

NCT03561454 is a clinical study titled "A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients". Single arm, prospective, multi-center, non-randomized study of subjects treated with single fraction, intra-operative radiation therapy at the time of lumpectomy for early stage breast cancer.To assess the rate of ipsilateral breast tumor recurrence in subjects treated with the Xoft Axxent Electroni...

What is the current status of trial NCT03561454?

This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2019-01-11. Estimated completion is 2029-08-01.

What conditions does trial NCT03561454 study?

This clinical trial studies the following conditions: Early Stage Breast Cancer.

What interventions are being tested in trial NCT03561454?

The interventions under investigation include: IORT (DEVICE).

Who is sponsoring clinical trial NCT03561454?

This trial is sponsored by MedStar Franklin Square Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03561454 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Early Stage Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03561454's enrollment target sits among peer trials

100 7th of 21 higher than 14 of 21 other Early Stage Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Stage Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03561454, the US trial registry maintained by the National Library of Medicine. NCT03561454 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.